[
  {
    "ts": null,
    "headline": "Edwards Lifesciences Corp. stock outperforms competitors on strong trading day",
    "summary": "Edwards Lifesciences Corp. stock outperforms competitors on strong trading day",
    "url": "https://finnhub.io/api/news?id=d6c39ab681bb44845d94a17e511007021413e2f84ea40023d7cc23eafe311dd8",
    "source": "MarketWatch",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1732553820,
      "headline": "Edwards Lifesciences Corp. stock outperforms competitors on strong trading day",
      "id": 131646667,
      "image": "",
      "related": "EW",
      "source": "MarketWatch",
      "summary": "Edwards Lifesciences Corp. stock outperforms competitors on strong trading day",
      "url": "https://finnhub.io/api/news?id=d6c39ab681bb44845d94a17e511007021413e2f84ea40023d7cc23eafe311dd8"
    }
  },
  {
    "ts": null,
    "headline": "Edwards Lifesciences announces positive results in one year TAVI trial",
    "summary": "Designed for patients needing a replacement valve, the company’s TAVI trial has found low rates of mortality after a year of study.",
    "url": "https://finnhub.io/api/news?id=28fe90dfdb43d398b08857fda3e4536004c3f4b64d3b8ee5cb0a6a9dabb8eb00",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1732538985,
      "headline": "Edwards Lifesciences announces positive results in one year TAVI trial",
      "id": 131629961,
      "image": "https://www.medicaldevice-network.com/wp-content/uploads/sites/23/2024/11/shutterstock_2489450877-2.jpg",
      "related": "EW",
      "source": "Yahoo",
      "summary": "Designed for patients needing a replacement valve, the company’s TAVI trial has found low rates of mortality after a year of study.",
      "url": "https://finnhub.io/api/news?id=28fe90dfdb43d398b08857fda3e4536004c3f4b64d3b8ee5cb0a6a9dabb8eb00"
    }
  },
  {
    "ts": null,
    "headline": "Edwards’ SAPIEN 3 Ultra RESILIA Valve Demonstrates Continued Excellent Outcomes for Patients in Real World Data",
    "summary": "LONDON, November 25, 2024--Edwards Lifesciences (NYSE: EW) today announced one-year data highlighting the continued outstanding performance of its SAPIEN 3 Ultra RESILIA valve. The data were presented at PCR London Valves 2024 and simultaneously published in the Journal of the American College of Cardiology (JACC): Cardiovascular Interventions.",
    "url": "https://finnhub.io/api/news?id=e1f2add6197c9d082e21dedcdead967e9a73ffb10b76cdc619837aeb4933f80e",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1732523400,
      "headline": "Edwards’ SAPIEN 3 Ultra RESILIA Valve Demonstrates Continued Excellent Outcomes for Patients in Real World Data",
      "id": 131622574,
      "image": "https://media.zenfs.com/en/business-wire.com/5040ffc30f8a22bc1a7ef8f5b2b5b61b",
      "related": "EW",
      "source": "Yahoo",
      "summary": "LONDON, November 25, 2024--Edwards Lifesciences (NYSE: EW) today announced one-year data highlighting the continued outstanding performance of its SAPIEN 3 Ultra RESILIA valve. The data were presented at PCR London Valves 2024 and simultaneously published in the Journal of the American College of Cardiology (JACC): Cardiovascular Interventions.",
      "url": "https://finnhub.io/api/news?id=e1f2add6197c9d082e21dedcdead967e9a73ffb10b76cdc619837aeb4933f80e"
    }
  }
]